Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Rubius Therapeutics Inc (RUBY)

Rubius Therapeutics Inc (RUBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Rubius Therapeutics Inc 124 WASHINGTON STREET SUITE 101 FOXBOROUGH MA 02035 USA

www.rubiustx.com P: 508-543-1720

Description:

Rubius Therapeutics, Inc. is a bio-technology company. It develops cellular therapies for the treatment of auto-immune, metabolic and other diseases. Rubius Therapeutics, Inc. is based in Cambridge, United States.

Key Statistics

Overview:

Market Capitalization, $K 5,158
Enterprise Value, $K -9,712
Shares Outstanding, K 90,483
Annual Sales, $ 0 K
Annual Net Income, $ -179,670 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -20,140 K
EBIT, $ -178,450 K
EBITDA, $ -172,200 K
60-Month Beta 2.20
% of Insider Shareholders 5.30%
% of Institutional Shareholders 0.00%
Float, K 85,687
% Float 94.70%
Short Volume Ratio 0.27

Growth:

1-Year Return -70.37%
3-Year Return -99.25%
5-Year Return -99.69%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 01/03/24
Earnings Per Share ttm -1.44
EPS Growth vs. Prev Year -10.76%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

RUBY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.34
Book Value/Share 0.17
Interest Coverage -45.55
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar